☆ 4.7 Article

Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma

JOURNAL OF CLINICAL ONCOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Microbiology

Comparison of Antibody Class-Specific SARS-CoV-2 Serologies for the Diagnosis of Acute COVID-19

Hans Verkerke et al.

Summary: Accurate diagnosis of acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is crucial for proper management of patients. Laboratory-developed class-specific clinical serology was found to have higher sensitivity and specificity in diagnosing SARS-CoV-2 infection in hospitalized patients, with IgA performing the best, especially in the early stages of infection.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

SARS-CoV-2 Vaccines

C. Buddy Creech et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Article Hematology

Tandem high-dose influenza vaccination is associated with more durable serologic immunity in patients with plasma cell dyscrasias

Andrew R. Branagan et al.

Summary: The study showed that tandem high-dose influenza vaccination in patients with plasma cell dyscrasias can lead to higher protection against influenza and result in more durable immunity against the virus. Similar vaccination strategies may also be necessary for achieving protective immunity against other emerging pathogens, such as novel coronavirus, in these patients.

BLOOD ADVANCES (2021)

添加到收藏夹

Letter Medicine, General & Internal

Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination

Venkata Viswanadh Edara et al.

Summary: This study investigates the neutralizing antibody response to 4 SARS-CoV-2 variants in individuals who have been infected or vaccinated.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury et al.

Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.

NATURE MEDICINE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2

Joseph E. Ebinger et al.

Summary: Virus-specific antibody levels after a single dose of the BNT162b2 vaccine in individuals previously infected with SARS-CoV-2 are similar to levels after two doses of the vaccine in infection-naive individuals. Post-vaccine symptoms were more prominent for those with prior infection after the first dose, but symptomology was similar between groups after the second dose.

NATURE MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection

Leonidas Stamatatos et al.

Summary: The study found that vaccination of both previously infected individuals and those who were not infected resulted in increased neutralizing antibody titers, with previously infected individuals showing a greater boost in neutralizing titers. Vaccination of naive individuals also elicited cross-neutralizing responses, but at lower titers.

SCIENCE (2021)

添加到收藏夹

Article Virology

Within-Host and Between-Host Evolution in SARS-CoV-2-New Variant's Source

Karin Moelling

Summary: Some newly emerging corona viral variants with high mutation rates have been found in immune compromised patients, showing potential to be sources of new variants with pandemic potential. Immunosuppressed patients may escape detection, highlighting the need for healthcare workers' attention and treatment.

VIRUSES-BASEL (2021)

添加到收藏夹

Article Hematology

Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapy

Binod Dhakal et al.

BLOOD (2021)

添加到收藏夹

Letter Oncology

Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma

Oliver Van Oekelen et al.

CANCER CELL (2021)

添加到收藏夹

Article Oncology

Response to mRNA vaccination for COVID-19 among patients with multiple myeloma

Samuel D. Stampfer et al.

Summary: Patients with multiple myeloma have impaired responses to mRNA vaccination against COVID-19, with those with active disease showing poorer responses. Factors such as age, renal function, immunoglobulin levels, among others, can predict vaccine responsiveness in these patients. Additionally, patients vaccinated with mRNA-1273 had higher anti-spike antibody levels compared to those vaccinated with BNT162b2.

LEUKEMIA (2021)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses

Jackson S. Turner et al.

Summary: SARS-CoV-2 mRNA vaccines induce a persistent germinal centre B cell response in humans, leading to the generation of robust humoral immunity, especially more significant in individuals previously infected with the virus.

NATURE (2021)

添加到收藏夹

Letter Medicine, General & Internal

Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants

Venkata-Viswanadh Edara et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Oncology

The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment

Evangelos Terpos et al.

Summary: Recent data shows suboptimal antibody response to COVID-19 vaccination in patients with hematological malignancies. Specifically, patients with multiple myeloma (MM) exhibit lower production of neutralizing antibodies (NAbs) after vaccination compared to healthy controls, especially when undergoing treatment with anti-CD38 or belamaf. Timely vaccination, possibly during treatment-free periods, is emphasized for this group of patients.

BLOOD CANCER JOURNAL (2021)

添加到收藏夹

Article Medicine, General & Internal

Racial/Ethnic Differences in COVID-19 Vaccine Hesitancy Among Health Care Workers in 2 Large Academic Hospitals

Florence M. Momplaisir et al.

Summary: Significant racial/ethnic disparities exist in COVID-19 vaccine hesitancy among healthcare workers, with Black, Hispanic or Latino, and Asian healthcare workers exhibiting higher levels of hesitancy compared to White healthcare workers. Reasons for vaccine hesitancy include concerns about side effects, the novelty of the vaccine, and a lack of knowledge about the vaccine.

JAMA NETWORK OPEN (2021)

添加到收藏夹

Article Oncology

Disease- and Therapy-Specific Impact on Humoral Immune Responses to COVID-19 Vaccination in Hematologic Malignancies

David J. Chung et al.

Summary: Patients with hematologic malignancy have compromised COVID-19 vaccine responses at baseline, which are further suppressed by certain therapies, leading to insufficient neutralizing capacity despite positive antibody titers. Refining vaccine response parameters is critical for guiding clinical care, including the consideration for booster vaccines in this vulnerable population.

BLOOD CANCER DISCOVERY (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

E. J. Anderson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Cell Biology

Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients

Mehul S. Suthar et al.

CELL REPORTS MEDICINE (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Early alterations in stem-like/marrow-resident T cells and innate and myeloid cells in preneoplastic gammopathy

Jithendra Kini Bailur et al.

JCI INSIGHT (2019)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.